Advanced Animal Diagnostics

Fund: 2018
Sector: Animal Health

Advanced Animal Diagnostics, Inc. (“AAD”) has developed diagnostic tests to help livestock producers detect diseases and manage the reproductive, nutritional and overall health status of animals.

visit website

AN2 Therapeutics

Fund: 2018
Sector: Life Sciences

AN2 Therapeutics is a clinical-stage biopharmaceutical company focused on novel medicines targeting infectious diseases.

visit website

AngelEye Health

Fund: 2018
Sector: Disruptive Technology

AngelEye Health has developed internet-based camera systems and educational and clinical communications software to transform neonatal care.

visit website

Appello Pharmaceuticals

Fund: 2018
Sector: Life Sciences

Appello Pharmaceuticals is a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.

visit website

Applied LifeSciences & Systems Poultry

Fund: 2018
Sector: Animal Health

Applied LifeSciences & Systems Poultry (“ALSSP”) is a poultry vaccine delivery device company developing a high-throughput vaccine delivery system to be used in the hatchery to individually vaccinate post-hatch chicks using a novel vaccination spray system.

visit website

Boragen

Fund: 2018
Sector: Life Sciences

Boragen is a small molecule development company focused on leveraging the unique chemical properties of Boron chemistry, both in crop protection and animal health.

visit website

Castle Biosciences

Fund: 2013, 2018
Sector: Life Sciences

Castle Biosciences is focused on developing and commercializing molecular diagnostics to aid health care professionals in assessing types and sub-types of tumors. Products focus on differentiating tumor types at the molecular level using various means of analyzing and comparing components of DNA.

visit website

Cerebrotech Medical Systems

Fund: 2013, 2018
Sector: Life Sciences

Cerebrotech Medical Systems has developed a non-invasive, continuous monitor for early detection of cerebral fluid change (primarily edema or bleeding) that can occur in a number of neurologic conditions, including stroke, traumatic brain injury, post brain surgery, etc.

visit website

Exubrion

Fund: 2018
Sector: Animal Health

Exubrion Therapeutics is developing a radiosynoviorthesis product to treat chronic osteoarthritis in dogs. The technology was originally developed for human use.

visit website

In The Bowl

Fund: 2018
Sector: Animal Health

In the Bowl Animal Health is providing pet owners with a creative alternative to current methods of drug administration.

visit website

Mindera

Fund: 2018
Sector: Life Sciences

Mindera Corporation has developed a proprietary micro biopsy tool used to extract a patient’s transcriptome. After processing via next-generation sequencing and analysis, dermatologists will be able to make personalized diagnoses and track disease progression.

visit website

PhaseBio Pharmaceuticals

Fund: 2018
Sector: Life Sciences

PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company committed to developing improved biotherapeutics for the treatment of orphan diseases, with an initial focus on cardiopulmonary indications.

visit website

ReVIDA Recovery Centers

Fund: 2018
Sector: Disruptive Technology

ReVIDA Recovery Centers operates seven medication assisted treatment clinics located throughout Tennessee and Virginia to assist opioid addicts in their recovery.

visit website

Silicon Ranch

Fund: 2013, 2018
Sector: Disruptive Technology

Silicon Ranch Corporation is a developer and operator of utility scale solar facilities that provides turn-key renewable energy solutions to industry and utility partners.

visit website